|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 14 studies with search of: | Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
Prevalence of Decreased Corneal Sensation in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
|
||||
| 2 | Completed |
Study of Efficacy and Safety of Privigen in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy
|
||||
| 3 | Recruiting |
Lipoic Acid to Treat Chronic Inflammatory Demyelinating Polyneuropathy
|
||||
| 4 | Completed |
Intravenous Immunoglobulin (IVIg) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
|
||||
| 5 | Withdrawn |
High-dose Cyclophosphamide for Moderate to Severe Refractory Chronic Inflammatory Demyelinating Polyneuropathy
|
||||
| 6 | Completed |
Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
|
||||
| 7 | Recruiting |
Hematopoietic Stem Cell Support in Chronic Inflammatory Demyelinating Polyneuropathy
|
||||
| 8 | Suspended |
Safety and Efficacy Study of Three Different Dosages of NewGam in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
|
||||
| 9 | Completed |
Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
|
||||
| 10 | Recruiting |
Randomized Open-label Trial to Compare Efficacy and Tolerance of Corticosteroids and IVIg
|
||||
| 11 | Completed |
Subcutaneous Immunoglobulin Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
|
||||
| 12 | Completed |
Study of CIDP Patients During IVIG Treatment
|
||||
| 13 | Completed |
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Chronic Inflammatory Demyelinating Polyneuropathy
|
||||
| 14 | Completed |
Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy
|